L957-0250 Screening compound: N-[3-(3-methylpiperidin-1-yl)propyl]-5-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,3,4-oxadiazole-2-carboxamide

L957-0250 Screening compound: N-[3-(3-methylpiperidin-1-yl)propyl]-5-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,3,4-oxadiazole-2-carboxamide
L957-0250 Screening compound: N-[3-(3-methylpiperidin-1-yl)propyl]-5-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,3,4-oxadiazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L957-0250
N-[3-(3-methylpiperidin-1-yl)propyl]-5-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,3,4-oxadiazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L957-0250

Molecular Formula

C22H31N5O4S (C22 H31 N5 O4 S)

Compound Name

N-[3-(3-methylpiperidin-1-yl)propyl]-5-[4-(pyrrolidine-1-sulfonyl)phenyl]-1,3,4-oxadiazole-2-carboxamide

IUPAC name

N-[3-(3-methylpiperidin-1-yl)propyl]-5-[4-(pyrrolidine-1-sulfonyl)phenyl]-134-oxadiazole-2-carboxamide

SMILES

CC1CN(CCCNC(c2nnc(-c(cc3)ccc3S(N3CCCC3)(=O)=O)o2)=O)CCC1

InChI

InChI=1S/C22H31N5O4S/c1-17-6-4-12-26(16-17)13-5-11-23-20(28)22-25-24-21(31-22)18-7-9-19(10-8-18)32(29,30)27-14-2-3-15-27/h7-10,17H,2-6,11-16H2,1H3,(H,23,28)/t17-/m0/s1

InChI Key

KYIMCXGZZBGHJV-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD27489609

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

461.59

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

1.824

Distribution Coefficient, logD

-0.747

Water Solubility, LogSw

-2.60

Polar Surface Area

91.002

Acid Dissociation Constant (pKa)

14.34

Base Dissociation Constant (pKb)

9.97

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

59.10

L957-0250 in Drug Discovery

Included in Screening Libraries

Regenerative Medicine Focused Library (23016 compounds)

SmartTM Library (51161 compounds)

Peptidomimetic Library (37031 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with L957-0250 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L957-0250?
Check Price and Availability of L957-0250, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L957-0250 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L957-0250
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L957-0250
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L957-0250 available by request